VIT and adenoma: We have previously reported a progressive decrease of VIT, a gene involved in remodelling of the ECM, in CAS of malignant CMTs compared to benign adenomas on both the RNA and protein level, and high expression of VIT to correlate with significantly better overall survival in human breast cancer patients [12].